FIB-4 Calculator

Use the FIB-4 Calculator

Free FIB-4 calculator scores liver fibrosis risk from age, AST, ALT, and platelet count, with age-adjusted cutoffs and a bonus APRI score for context.

How to Use FIB-4 Calculator

1. Step 1: Enter your age and liver enzymes

   Type your age in years, then your AST and ALT values in U/L from your most recent blood test.

2. Step 2: Enter your platelet count

   Add your platelet count and pick the matching unit: ×10⁹/L (e.g. 200) or the raw per-µL count (e.g. 200000).

3. Step 3: Read your FIB-4 index

   The FIB-4 score appears instantly with a Low, Indeterminate, or High badge and a color-coded risk bar.

4. Step 4: Check the age-adjusted cutoff

   If you are 65 or older, the calculator automatically raises the low-risk threshold from 1.45 to 2.0 to cut false positives.

5. Step 5: Add AST upper limit for APRI

   Open the optional field and enter your AST upper limit (often 35–40) to get a second fibrosis score, APRI, for context.

Key Features

• FIB-4 index from age, AST, ALT, and platelet count
• Low / indeterminate / high fibrosis risk classification
• Age-adjusted cutoff (2.0) applied automatically at age 65+
• Optional APRI score using your AST upper limit
• Platelet unit toggle (×10⁹/L or per µL) plus copyable summary

Understanding Results

Formula

The FIB-4 index is (Age × AST) ÷ (Platelet count × √ALT). Age is in years, AST and ALT are in U/L, and platelets are in ×10⁵/L (the same figure a CBC reports as 10³/µL). The equation deliberately rewards a falling platelet count and a rising AST — the two lab changes that track most closely with a stiffening liver. A worked case: a 60-year-old with AST 58, ALT 30, and platelets 140 scores (60 × 58) ÷ (140 × √30) = 3,480 ÷ 767 = 4.54, a high-risk result.

Reference Ranges & Interpretation

Standard cutoffs are below 1.45 = low risk (advanced fibrosis ruled out with ~90% negative predictive value), 1.45–3.25 = indeterminate, and above 3.25 = high risk for stage F3–F4 fibrosis. Because age sits in the numerator, adults 65 and older run high by default, so this calculator raises the low-risk cutoff to 2.0 past that age. The thresholds are validated for chronic hepatitis C and NAFLD/MASLD; FIB-4 is not designed for adults under 35, where it underperforms.

Assumptions & Limitations

FIB-4 estimates a probability, not a diagnosis. Anything that independently lowers platelets — immune thrombocytopenia, recent chemotherapy, or hypersplenism — inflates the score, and an acute hepatitis flare spikes AST, both producing false highs; retest once enzymes settle. A low or indeterminate score never replaces clinical judgment, and any high result should be confirmed with transient elastography (FibroScan) or, rarely, biopsy. Always review your number with a healthcare professional before acting on it.

Complete Guide: FIB-4 Calculator

The FIB-4 calculator can rule out advanced liver scarring in roughly 90% of patients without a single needle, which is why this liver fibrosis calculator has quietly become the first test ordered when fatty liver or hepatitis is suspected. It combines four numbers you almost certainly already have on file — your age, AST, ALT, and platelet count — into one index that sorts people into three buckets: probably fine, probably scarred, or unclear. The catch is that most people misread it. They assume a normal ALT means a healthy liver, or that an “indeterminate” result is a dead end. Both assumptions are wrong, and this guide explains why.

What the FIB-4 Calculator Score Really Tells You

FIB-4 stands for Fibrosis-4. It estimates the chance that the liver has progressed to advanced fibrosis — stages F3 (bridging fibrosis) and F4 (cirrhosis) on the 0–4 METAVIR scale. It does not grade inflammation, measure fat, or diagnose a specific disease. What it does well is separate the large group of people who can safely be reassured from the small group who need a hepatologist. Developed in 2006 for HIV/hepatitis C co-infection, it was later validated across hepatitis C, hepatitis B, and non-alcoholic fatty liver disease (now called MASLD), which is why primary-care and diabetes guidelines now treat it as the front-line screen for the estimated 1 in 4 adults worldwide with fatty liver.

Three Myths That Send People to the Wrong Test

Myth 1: “My ALT is normal, so my liver is fine.” Up to 70% of people with significant fibrosis from fatty liver have ALT values inside the lab's reference range. FIB-4 catches many of them because it leans on the AST-to-ALT relationship and the platelet drop that comes with a stiffening liver, not on a single enzyme. Myth 2: “You need a biopsy to know.” Biopsy samples roughly 1/50,000th of the liver and carries a real bleeding risk; FIB-4 plus an elastography scan now replaces biopsy for most fibrosis staging. Myth 3: “An indeterminate score is useless.” It is actually doing its job — narrowing a whole population down to the ~30% who need one more test instead of biopsying everyone.

The Formula and a Worked Example

The equation is FIB-4 = (Age × AST) ÷ (Platelet count × √ALT), where age is in years, AST and ALT are in U/L, and platelets are in ×10⁵/L (the same number a CBC reports as 10³/µL). If you are unsure what your own platelet value means in isolation, our platelet count calculator grades it against normal, thrombocytopenia, and thrombocytosis ranges. Notice how the math punishes a falling platelet count and a rising AST — the two changes that track most closely with scarring. Take a 60-year-old with AST 58, ALT 30, and platelets 140: FIB-4 = (60 × 58) ÷ (140 × √30) = 3,480 ÷ (140 × 5.48) = 3,480 ÷ 767 = 4.54. That sits well above the 3.25 high-risk threshold, so this person needs hepatology referral, not reassurance. Because the same AST/ALT pair drives our AST/ALT ratio calculator, the two tools pair naturally — a De Ritis ratio above 1 plus a high FIB-4 strengthens the case for fibrosis.

Cutoffs, and Why Age 65 Changes Them

The classic thresholds are below 1.45 = low risk, 1.45 to 3.25 = indeterminate, and above 3.25 = high risk. The low cutoff is built for ruling out: a FIB-4 under 1.45 has about 90% negative predictive value for advanced fibrosis. The high cutoff is built for ruling in, with a positive predictive value around 65–80% depending on the population. But age is baked into the numerator, so older adults drift upward by default. In people 65 and over, using 1.45 produces too many false positives, so validation studies recommend raising the lower cutoff to 2.0. The calculator above applies this automatically once age hits 65.

FIB-4 vs. APRI vs. FibroScan vs. Biopsy

FIB-4 is not the only non-invasive option, and knowing where it sits helps you read the result. APRI uses just AST and platelets and is cheaper to remember but slightly less accurate; the calculator above computes it for you when you enter your lab's AST upper limit. Transient elastography (FibroScan) physically measures liver stiffness in kilopascals and is the usual confirmatory test after an abnormal FIB-4. Biopsy remains the reference standard but is reserved for unclear cases. A sensible pathway: FIB-4 first, FibroScan if the score is indeterminate or high, biopsy only if the picture still does not add up.

Once cirrhosis is on the table, FIB-4 hands off to prognostic scores. The MELD score calculator and Child-Pugh calculator take over to grade severity and predict outcomes, while a broader liver function calculator helps interpret the full enzyme panel that flagged the problem in the first place.

What to Do With an Indeterminate Score

Landing between 1.45 and 3.25 frustrates people, but it is the expected outcome for roughly 30% of those screened. The correct move is a second non-invasive test rather than repeating the bloods or jumping to biopsy. Transient elastography is the usual next step; where it is unavailable, an Enhanced Liver Fibrosis (ELF) blood test serves the same purpose. The point of the indeterminate zone is triage efficiency: instead of scanning everyone, the score reserves the expensive equipment for the minority whose FIB-4 could not settle the question. If your number sits here, treat it as “needs one more look,” not “something is wrong.”

When FIB-4 Gives the Wrong Answer

Three situations distort the score. First, anything that independently drops platelets — immune thrombocytopenia, recent chemotherapy, hypersplenism unrelated to liver disease — inflates FIB-4 and can produce a false high. Second, an acute hepatitis flare sends AST soaring for reasons that have nothing to do with chronic scarring, so a FIB-4 drawn during an alcohol binge or a viral spike overstates fibrosis; wait for enzymes to settle and recheck. Third, age over-weights the result in the very old and under-weights it in adults under 35, where the score simply was not validated. Read FIB-4 as a probability, not a verdict, and always pair an abnormal number with the clinical picture and a confirmatory scan before drawing conclusions.

References

1. Sterling RK, et al. Development of a simple noninvasive index to predict significant fibrosis (FIB-4). Hepatology. PubMed 2006
2. McPherson S, et al. Age as a confounding factor for the accuracy of non-invasive fibrosis tests. Am J Gastroenterol. PubMed 2017

Frequently Asked Questions